Biology and clinical application of regulatory RNAs in hepatocellular carcinoma

Pea, A., Jamieson, N. B. and Braconi, C. (2021) Biology and clinical application of regulatory RNAs in hepatocellular carcinoma. Hepatology, 73(S1), pp. 38-48. (doi: 10.1002/hep.31225) (PMID:32160335)

[img] Text
212482.pdf - Accepted Version



The majority of the human genome comprises of DNA genes that are translated into RNAs but not into proteins. These RNA molecules are named non‐coding RNAs (ncRNA). While in the past it was thought that ncRNAs would be redundant without relevant functions, it is now well established that ncRNAs identify a class of regulatory molecules that finely tune cell homeostasis and are deregulated in disease states, including Hepatocellular Carcinoma (HCC). Of note, the number of ncRNAs within a cell increases progressively with the complexity of the species indicating their essential role in the maintenance of regulatory networks that impact the intricacy of the organism. ncRNAs have been demonstrated to mediate HCC development and progression by affecting intrinsic cancer cell signaling and cross talk between malignant cells and the microenvironment. They hold promise as clinical biomarkers, but further evidence is warranted prior to translation and integration within clinical practice.

Item Type:Articles
Glasgow Author(s) Enlighten ID:Jamieson, Dr Nigel and Braconi, Dr Chiara and pea, Dr Antonio
Authors: Pea, A., Jamieson, N. B., and Braconi, C.
College/School:College of Medical Veterinary and Life Sciences > School of Cancer Sciences
Journal Name:Hepatology
ISSN (Online):1527-3350
Published Online:11 March 2020
Copyright Holders:Copyright © 2020 American Association for the Study of Liver Diseases
First Published:First published in Hepatology 73(S1): 38-48
Publisher Policy:Reproduced in accordance with the publisher copyright policy

University Staff: Request a correction | Enlighten Editors: Update this record